Market Recap: Revolution Medicines Inc (RVMD)’s Negative Momentum, Closing at 57.37

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Revolution Medicines Inc (NASDAQ: RVMD) was $57.37 for the day, down -1.31% from the previous closing price of $58.13. In other words, the price has decreased by -$1.31 from its previous closing price. On the day, 1.72 million shares were traded. RVMD stock price reached its highest trading level at $58.3999 during the session, while it also had its lowest trading level at $57.27.

Ratios:

Our analysis of RVMD’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.24 and its Current Ratio is at 14.24. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on July 16, 2024, Reiterated its Buy rating but revised its target price to $62 from $46 previously.

On July 12, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $52.

On July 08, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $63.Jefferies initiated its Buy rating on July 08, 2024, with a $63 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 13 ’24 when STEPHEN M. KELSEY bought 16,666 shares for $59.33 per share.

Cislini Jeff sold 6,000 shares of RVMD for $360,000 on Nov 06 ’24. The General Counsel now owns 45,634 shares after completing the transaction at $60.00 per share. On Nov 06 ’24, another insider, JEFFREY TODD CISLINI, who serves as the Officer of the company, bought 6,000 shares for $56.75 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVMD now has a Market Capitalization of 9650723840 and an Enterprise Value of 8187971584. For the stock, the TTM Price-to-Sale (P/S) ratio is 13041.54 while its Price-to-Book (P/B) ratio in mrq is 6.14. Its current Enterprise Value per Revenue stands at 11035.002 whereas that against EBITDA is -13.173.

Stock Price History:

Over the past 52 weeks, RVMD has reached a high of $62.40, while it has fallen to a 52-week low of $20.47. The 50-Day Moving Average of the stock is 17.38%, while the 200-Day Moving Average is calculated to be 42.28%.

Shares Statistics:

RVMD traded an average of 1.14M shares per day over the past three months and 1793580 shares per day over the past ten days. A total of 164.67M shares are outstanding, with a floating share count of 141.22M. Insiders hold about 16.05% of the company’s shares, while institutions hold 87.04% stake in the company. Shares short for RVMD as of 1730332800 were 18144306 with a Short Ratio of 15.89, compared to 1727654400 on 16342734. Therefore, it implies a Short% of Shares Outstanding of 18144306 and a Short% of Float of 11.5200005.

Most Popular